<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Gastric Carcinoma - Okell Surgery Notes</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="../styles/main.css">
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams'
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <div class="container">
        <article class="document-section" role="main">
            <!-- Top Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="21-fistula-in-ano.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 36.6%;"></div>
                        </div>
                       <span class="progress-text">Topic 22 of 60</span>
                    </div>
                    <a href="23-head-injury.html" class="nav-button">
                        <span class="nav-text">Next: Head Injury</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

            <header class="section-header">
                <h1 class="section-title">GASTRIC CARCINOMA</h1>
                <div class="title-underline"></div>
            </header>

            <main class="section-content">
                
                <!-- START: etiology -->
                <section id="etiology" class="content-section">
                    <h2 class="section-heading">Predisposing Factors</h2>
                    <div class="content-card">
                        <ol class="enhanced-list">
                            <li><strong>H. pylori infection</strong></li>
                            <li>Gastric ulcers</li>
                            <li>Chronic gastritis (atrophic or pernicious anemia)</li>
                            <li>Gastric adenomas</li>
                            <li>Cigarette smoking and alcohol consumption</li>
                            <li><strong>Diet:</strong> Nitrosamines in food preservation, smoked fish/meat.</li>
                            <li>Partial gastrectomy (bilious reflux)</li>
                            <li>Barrett's esophagus</li>
                            <li>Radiation therapy</li>
                            <li>Genetic Factors (Familial history)</li>
                        </ol>
                    </div>
                </section>
                <!-- END: etiology -->

                <!-- START: clinical-presentation -->
                <section id="clinical-presentation" class="content-section">
                    <h2 class="section-heading">Clinical Presentation</h2>
                    <div class="content-card">
                        <h3>History (The 5 A's)</h3>
                        <p>Most gastric cancers present at an advanced stage. The presentations are often non-specific, classically summarized as the 5 A's:</p>
                        <ul class="enhanced-list">
                            <li><strong>Asthenia</strong> (Weakness/Fatigue)</li>
                            <li><strong>Abdominal pain</strong></li>
                            <li><strong>Anorexia</strong></li>
                            <li><strong>Anaemia</strong></li>
                            <li><strong>Achlorhydria</strong> (Reduced stomach acid)</li>
                        </ul>

                        <h4>Specific Symptoms</h4>
                        <ol class="enhanced-list">
                            <li><strong>Weight loss:</strong> Most common symptom.</li>
                            <li><strong>Abdominal pain:</strong> Epigastric, substernal, or back. May mimic peptic ulcer disease.</li>
                            <li><strong>Vomiting:</strong> Especially if distal tumors cause pyloric obstruction. Associated with early satiety.</li>
                            <li><strong>Constipation:</strong> Due to reduced intake.</li>
                            <li><strong>Bleeding:</strong> Hematemesis and melena (acute or chronic).</li>
                            <li><strong>Dysphagia:</strong> For tumors at the cardioesophageal junction (fundus).</li>
                        </ol>

                        <h3>Physical Examination</h3>
                        <p>May not reveal abnormality except in advanced disease.</p>
                        <ul class="enhanced-list">
                            <li><strong>General:</strong> Anemia, Dehydration, Wasting (cachexia).</li>
                            <li><strong>Abdominal Mass:</strong> Palpable epigastric mass, hepatic enlargement, or succussion splash (obstruction).</li>
                            <li><strong>Metastatic Signs:</strong>
                                <ul>
                                    <li><strong>Virchow's node (Troisier's sign):</strong> Left supraclavicular lymph node.</li>
                                    <li><strong>Sister Mary Joseph's nodule:</strong> Umbilical nodules.</li>
                                    <li><strong>Blumer's shelf:</strong> Metastatic deposits in the pouch of Douglas felt on DRE.</li>
                                    <li><strong>Krukenberg tumor:</strong> Ovarian metastases.</li>
                                    <li><strong>Trousseau's sign:</strong> Migratory superficial thrombophlebitis.</li>
                                    <li><strong>Jaundice/Ascites:</strong> Liver mets or peritoneal seeding.</li>
                                </ul>
                            </li>
                        </ul>
                    </div>
                </section>
                <!-- END: clinical-presentation -->

                <!-- START: investigations -->
                <section id="investigations" class="content-section">
                    <h2 class="section-heading">Investigations</h2>
                    <div class="content-card">
                        <h3>Imaging</h3>
                        <ol class="enhanced-list">
                            <li><strong>Gastroscopy & Biopsy (Gold Standard):</strong> Allows visualization and histological confirmation. Multiple biopsies (4-6) and brush cytology increase yield.</li>
                            <li><strong>Barium Meal (Double Contrast):</strong> If endoscopy unavailable. Findings: Filling defects, ulcerated mass, loss of distensibility ("linitis plastica"), enlarged folds.</li>
                            <li><strong>Endoscopic Ultrasonography (EUS):</strong> Best for assessing depth of invasion (T-stage) and regional nodes.</li>
                            <li><strong>CT Scan:</strong> For staging (metastasis, ascites, organ extension).</li>
                            <li><strong>Laparoscopy:</strong> To assess operability, peritoneal seeding, and obtain cytology.</li>
                        </ol>

                        <h3>Laboratory</h3>
                        <ul class="enhanced-list">
                            <li><strong>FHG:</strong> Microcytic hypochromic anemia (blood loss) or Megaloblastic (pernicious anemia).</li>
                            <li><strong>LFTs:</strong> Abnormal in liver metastasis.</li>
                            <li><strong>Tumor Markers:</strong> CEA (Carcinoembryonic antigen) - helpful for follow-up.</li>
                            <li><strong>Stool Occult Blood:</strong> Frequently positive.</li>
                        </ul>
                    </div>
                </section>
                <!-- END: investigations -->

                <!-- START: staging -->
                <section id="staging" class="content-section">
                    <h2 class="section-heading">TNM Staging</h2>
                    <div class="content-card">
                        <div class="table-container">
                            <table>
                                <tr>
                                    <th>Primary Tumor (T)</th>
                                    <th>Regional Nodes (N)</th>
                                    <th>Metastasis (M)</th>
                                </tr>
                                <tr>
                                    <td><strong>Tis:</strong> Carcinoma in situ</td>
                                    <td><strong>N1:</strong> Perigastric nodes</td>
                                    <td><strong>M0:</strong> No metastasis</td>
                                </tr>
                                <tr>
                                    <td><strong>T1:</strong> Invades submucosa</td>
                                    <td><strong>N2:</strong> Regional nodes</td>
                                    <td><strong>M1:</strong> Distant metastasis</td>
                                </tr>
                                <tr>
                                    <td><strong>T2:</strong> Invades muscularis propria</td>
                                    <td><strong>N3:</strong> IVC/Aorta nodes</td>
                                    <td></td>
                                </tr>
                                <tr>
                                    <td><strong>T3:</strong> Penetrates serosa/adventitia</td>
                                    <td></td>
                                    <td></td>
                                </tr>
                                <tr>
                                    <td><strong>T4:</strong> Invades adjacent structures</td>
                                    <td></td>
                                    <td></td>
                                </tr>
                            </table>
                        </div>
                    </div>
                </section>
                <!-- END: staging -->

                <!-- START: management -->
                <section id="management" class="content-section">
                    <h2 class="section-heading">MANAGEMENT</h2>
                    <div class="content-card">
                        <h3>Surgical Management</h3>
                        
                        <h4>1. Mucosal Resection</h4>
                        <p>For carcinoma in situ (CIS) confined to mucosa (< 2cm). Done endoscopically.</p>

                        <h4>2. Gastrectomy (Curative)</h4>
                        <p><strong>Goal:</strong> Surgical margins free of tumor (8-10 cm clearance).</p>
                        <ul>
                            <li><strong>Partial Gastrectomy (Billroth):</strong> For distal tumors. Reconstruction via Gastrojejunostomy.</li>
                            <li><strong>Total Gastrectomy:</strong> For proximal (cardia/fundus) tumors. Reconstruction via <strong>Roux-en-Y esophago-jejunostomy</strong> (prevents alkaline reflux).</li>
                        </ul>

                        <h4>3. Lymphadenectomy (Extent)</h4>
                        <p><strong>R1 Gastrectomy:</strong> Removes Group I (N1) nodes (perigastric).<br>
                        <strong>R2 Gastrectomy:</strong> Removes Group II (N2) nodes (along hepatic, splenic, celiac arteries) en bloc with omentum. Standard curative intent.<br>
                        <strong>R3 Gastrectomy:</strong> Includes Group III (N3) nodes (para-aortic/retropancreatic). Often involves splenectomy/pancreatectomy.</p>

                        <h3>Palliative Surgery</h3>
                        <p>For unresectable tumors to relieve obstruction or bleeding.</p>
                        <ul class="enhanced-list">
                            <li><strong>Billroth II:</strong> Resection of distal stomach with gastrojejunostomy.</li>
                            <li><strong>Gastrostomy:</strong> For feeding.</li>
                            <li><strong>Stenting:</strong> For gastro-esophageal junction obstruction.</li>
                        </ul>

                        <h3>Adjuvant Therapy</h3>
                        <ul class="enhanced-list">
                            <li><strong>Chemotherapy:</strong> Gastric cancers are relatively sensitive. Combination therapy (5-FU, Doxorubicin, Mitomycin C) is most effective.</li>
                            <li><strong>Radiotherapy:</strong> Generally radio-resistant, but useful for palliation of dysphagia or pain.</li>
                        </ul>

                        <h3>Prevention</h3>
                        <ul class="enhanced-list">
                            <li>Triple therapy to eradicate <em>H. pylori</em>.</li>
                            <li>Dietary modification (High Vitamins C, E, A).</li>
                            <li>Surveillance endoscopy for high-risk groups (Family history, Post-gastrectomy).</li>
                        </ul>
                    </div>
                </section>
                <!-- END: management -->

            </main>

            <!-- Bottom Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="21-fistula-in-ano.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 36.6%;"></div>
                        </div>
                       <span class="progress-text">Topic 22 of 60</span>
                    </div>
                    <a href="23-head-injury.html" class="nav-button">
                        <span class="nav-text">Next: Head Injury</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>
        </article>
    </div>
    <script src="../js/navigation.js"></script>
</body>
</html>